Nanotechnology boosts war on superbugs

October 13, 2008

This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at UCL are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. The researchers, led by Dr Rachel McKendry and Professor Gabriel Aeppli, developed ultra-sensitive probes capable of providing new insight into how antibiotics work, paving the way for the development of more effective new drugs.

During the study Dr McKendry, Joseph Ndieyira, Moyu Watari and coworkers used cantilever arrays - tiny levers no wider than a human hair - to examine the process which ordinarily takes place in the body when vancomycin binds itself to the surface of the bacteria. They coated the cantilever array with mucopeptides from bacterial cell walls and found that as the antibiotic attaches itself, it generates a surface stress on the bacteria which can be detected by a tiny bending of the levers. The team suggests that this stress contributes to the disruption of the cell walls and the breakdown of the bacteria.

The interdisciplinary team went on to compare how vancomycin interacts with both non-resistant and resistant strains of bacteria. The 'superbugs' are resistant to antibiotics because of a simple mutation which deletes a single hydrogen bond from the structure of their cell walls. This small change makes it approximately 1,000 times harder for the antibiotic to attach itself to the bug, leaving it much less able to disrupt the cells' structure, and therefore therapeutically ineffective.

"There has been an alarming growth in antibiotic-resistant hospital 'superbugs' such as MRSA and vancomycin-resistant Enterococci (VRE)," said Dr McKendry. "This is a major global health problem and is driving the development of new technologies to investigate antibiotics and how they work.

"The cell wall of these bugs is weakened by the antibiotic, ultimately killing the bacteria," she continued. "Our research on cantilever sensors suggests that the cell wall is disrupted by a combination of local antibiotic-mucopeptide binding and the spatial mechanical connectivity of these events. Investigating both these binding and mechanical influences on the cells' structure could lead to the development of more powerful and effective antibiotics in future."

"This work at the LCN demonstrates the effectiveness of silicon-based cantilevers for drug screening applications," added Professor Gabriel Aeppli, Director of the LCN. "According to the Health Protection Agency, during 2007 there were around 7,000 cases of MRSA and more than a thousand cases of VRE in England alone. In recent decades the introduction of new antibiotics has slowed to a trickle but without effective new drugs the number of these fatal infections will increase."

University College London

---

---

	Beyond Antibiotics: Strategies for Living in a World of Emerging Infections and Antibiotic-Resistant Bacteria by Michael A. Schmidt Ph.D (Author) At a time when the numbers of emerging infections and antibiotic-resistant bacteria are rising sharply, the supply of new antibiotic drugs has been steadily decreasing. In addition, many health providers have failed to consider that our bodies are cloaked in a blanket of bacteria so pervasive that the bacterial cells outnumber our “human” cells by a factor of ten. In short, we are living in a microbe’s world and cannot ignore the very real potential for untreatable serious infections. In this timely book, Dr. Michael Schmidt proposes we focus on strengthening ourselves by thinking of our bodies as a “human-microbe hybrid.” This requires taking action to raise our defenses, while preserving the integrity of the microbial elements that live on and within us. Drawing on the...
	CONTAINING METHICILLIN-RESISTANT S AUREUS Surveillance, control, and treatment methods MRSA is endemic in many hospitals and long-term care facilities, ... is on the rise. (Postgraduate Medicine) by JTE Multimedia Methicillin-resistant Staphylococcus aureus (MRSA), an organism resistant to many drugs, is seen with increasing frequency in hospitals and long-term care facilities. It can cause life-threatening disease, and treatment options are limited. In this article, Dr Simor summarizes current knowledge about the epidemiologic and risk factors, diagnosis, and management of MRSA. Original Publication Date: October 2001
	Mrsa (Methicillin Resistant Staphylococcus Aureus) Infections and Treatment by Manal M. Baddour (Author) Incidents of methicillin-resistant Staphylococcus aureus (MRSA) have been prominent in the news over the past few years, drawing attention to a type of infection that is resistant to certain antibiotics. Staphylococcus aureus has three features that make it distinct among most other clinically important bacteria. Not only do MRSA infections lead to higher lengths of stay and more cost then MSSA infections, but more importantly, MRSA infections lead to a higher mortality. MRSA is no longer confined to hospitals and hospital-attending people, it has now vigorously invaded recreational, rehabilitation, sporting and teaching facilities.
	Management of Multiple Drug-Resistant Infections (Infectious Disease) by Stephen H. Gillespie (Editor) A comprehensive and cutting-edge review of how practicing physicians can best treat multiple drug resistance in bacterial, viral, protozoal, and helminthic infections. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegalovirals is also discussed, as are those measures necessary to prevent the spread of infections patients.
	ADDRESSING EMERGING INFECTIONS: The partnership between public health and primary care physicians (Postgraduate Medicine) by JTE Multimedia In response to concerns about emerging infections, the Minnesota Department of Health, in conjunction with the Centers for Disease Control and Prevention, developed a model emerging infections program in 1995. The authors' experience with the program has demonstrated the key role clinicians have as partners with public health agencies in identifying and reporting disease cases, educating patients about infectious risks, and preventing emerging infections. This partnership is well illustrated by two examples from Minnesota: a recent outbreak of Neisseria meningitidis infection in a rural area and a laboratory surveillance study of invasive and drug-resistant Streptococcus pneumoniae infections in a metropolitan area. Original Publication Date: August 1999
	Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (Storey Medicinal Herb Guide) by Stephen Harrod Buhner (Author) Current information about antibiotic resistant microbes and the herbs that are effective in fighting them.
	Resistant Infections (Current Controversies) by Debra A Miller (Author)
	Herbal Antibiotics, 2nd Edition: Natural Alternatives for Treating Drug-resistant Bacteria by Stephen Harrod Buhner (Author) Antibiotic-resistant infections are alarmingly on the rise, and many people are looking for sound information on herbal alternatives to standard antibiotics. In this indispensable reference, herbal expert Stephen Harrod Buhner explains the roots of antibiotic resistance, explores the value of herbal treatments, and provides in-depth profiles of 30 valuable herbs, noting for each one its antibiotic properties, methods for collection and preparation, dosages, potential side effects, contraindications, and alternatives. As we prepare for the end of antibiotics, this comprehensive guide is a must-have in every family's medicine cabinet.
	Transmission of MRSA Traced to breast milk.(Clinical Rounds)(Methicillin-resistant Staphylococcus aureus): An article from: Skin & Allergy News by Miriam E. Tucker (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2005. The length of the article is 362 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Transmission of MRSA Traced to breast milk.(Clinical Rounds)(Methicillin-resistant Staphylococcus aureus) Author: Miriam E. Tucker Publication: Skin & Allergy News (Magazine/Journal) Date: February 1, 2005 Publisher: International Medical News Group Volume: 36 Issue: 2 Page: 55(1) Distributed by Thompson...
	Resistant 'superbugs' create need for novel antibiotics.(Reprint): An article from: Dermatology Nursing by Teri Capriotti (Author) This digital document is an article from Dermatology Nursing, published by Thomson Gale on February 1, 2007. The length of the article is 4367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Resistant 'superbugs' create need for novel antibiotics.(Reprint) Author: Teri Capriotti Publication: Dermatology Nursing (Magazine/Journal) Date: February 1, 2007 Publisher: Thomson Gale Volume: 19 Issue: 1 Page: 65(6) Article Type: Reprint Distributed by Thomson...